Analysts Have Conflicting Sentiments on These Healthcare Companies: Resmed (RMD) and Scholar Rock Holding (SRRK)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Resmed (RMD – Research Report) and Scholar Rock Holding (SRRK – Research Report).
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Resmed (RMD)
In a report released today, Jonathan Block from Stifel Nicolaus maintained a Hold rating on Resmed, with a price target of $265.00. The company’s shares closed last Friday at $230.84.
According to TipRanks.com, Block is a 4-star analyst with an average return of
Currently, the analyst consensus on Resmed is a Moderate Buy with an average price target of $296.20.
See today’s best-performing stocks on TipRanks >>
Scholar Rock Holding (SRRK)
In a report released today, Tessa Romero from J.P. Morgan maintained a Buy rating on Scholar Rock Holding, with a price target of $50.00. The company’s shares closed last Friday at $40.01.
According to TipRanks.com, Romero is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Scholar Rock Holding with a $56.00 average price target, a 32.9% upside from current levels. In a report issued on March 5, TipRanks – Google also upgraded the stock to Buy with a $53.00 price target.
